AnaCardio is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Startup Funding News
New startup rounds, lead investors and the businesses behind the funding.
54 rounds · $4.8B disclosed · $33.4M median
| Company | Amount | Stage / sector | Lead investor | Announced |
|---|---|---|---|---|
| AnaCardio AnaCardio is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure. | €62.5M | Series B Healthtech | — | |
| Aptadir Therapeutics A Milan-based biotech company developing novel treatments for difficult to treat genetic conditions. | $45M | Seed Healthtech | — | |
| Basecamp Research Basecamp Research combines DNA analysis and environmental monitoring in its BaseDiscovery platform. | $140M | Series C+ Healthtech | — | |
| Biolevate Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing. | €30M | Series A Healthtech | — | |
| Tandem Health AI medical assistants and clinical workflow software for healthcare providers. | $100M | Series B Healthtech | Scaleup Europe Fund | |
| Implicity Implicity developed a remote monitoring platform for patients with connected pacemakers and defibrillators. | €35M | Growth Healthtech | — | |
| Lupin Dental Lupin Dental is a Montpellier-based early-stage robotics company focused on developing innovative dental technologies. | €15M | Series A Healthtech | — | |
| Pixelgen Technologies Sweden-based provider of a platform for new applications in cell-to-cell interactions and tissue. | $15.5M | Series B Healthtech | — | |
| Aisel Health Aisel Health is the Danish HealthTech company building an Operating System (OS) purpose-built for psychiatry and mental health. | €1.7M | Pre-seed Healthtech | — | |
| Computomics Uses bioinformatics to analyse crop performance. | €6.3M | Series B Agritech | — | |
| Mironid Targeted therapeutic innovation to improve health and quality of life. | $46M | Series B Healthtech | — | |
| Eversion Eversion wants to offer people with musculoskeletal complaints a data-based, transparent and sustainable solution. | €2.3M | Seed Healthtech | — | |
| Vivid Dx Vivid Dx is an Oxford, UK-based provider of a precision diagnostics platform improving pathogen detection and antimicrobial resistance (AMR) testing. | $15M | Seed Healthtech | — | |
| Neko Health non-invasive medical scanning technology. | $700M | Series C+ Healthtech | — | |
| Alchemab Therapeutics Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases. | £25M | Series A Healthtech | — | |
| Trimtech Therapeutics biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases. | £10.6M | Seed Healthtech | — | |
| CeQur CeQur is a medical device company that develops and manufactures wearable, injection-free insulin delivery solutions for people with diabetes. | $100M | Series C+ Healthtech | — | |
| Ona Therapeutics Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer. | $86.6M | Series B Healthtech | — | |
| Semble Semble provides practice management software, workflows and integrations for private medical practices. | £30M | Series C+ Healthtech | — | |
| NUCLIDIUM Swiss clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer. | CHF 26M | Series B Healthtech | — | |
| Lucis French startup focused on expanding access to preventive health testing. | $20M | Series A Healthtech | — | |
| Efferon The Efferon company develops devices with polymer sorbents that help purify the blood during severe conditions of patients with COVID-19. | €2.5M | Seed Healthtech | — | |
| Imperagen ultra-fast enzyme engineering platform. | £5M | Seed Healthtech | — | |
| Uromems UroMems is a medical device company developing smart active implantable technology to treat stress urinary incontinence in women and men. | $60M | Growth Healthtech | — | |
| NVision Imaging Developer of MRI polarizers and hyperpolarized imaging agents. | $55M | Series B Healthtech | — |
A Milan-based biotech company developing novel treatments for difficult to treat genetic conditions.
Basecamp Research combines DNA analysis and environmental monitoring in its BaseDiscovery platform.
Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing.
AI medical assistants and clinical workflow software for healthcare providers.
Implicity developed a remote monitoring platform for patients with connected pacemakers and defibrillators.
Lupin Dental is a Montpellier-based early-stage robotics company focused on developing innovative dental technologies.
Sweden-based provider of a platform for new applications in cell-to-cell interactions and tissue.
Aisel Health is the Danish HealthTech company building an Operating System (OS) purpose-built for psychiatry and mental health.
Uses bioinformatics to analyse crop performance.
Targeted therapeutic innovation to improve health and quality of life.
Eversion wants to offer people with musculoskeletal complaints a data-based, transparent and sustainable solution.
Vivid Dx is an Oxford, UK-based provider of a precision diagnostics platform improving pathogen detection and antimicrobial resistance (AMR) testing.
non-invasive medical scanning technology.
Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases.
biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases.
CeQur is a medical device company that develops and manufactures wearable, injection-free insulin delivery solutions for people with diabetes.
Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
Semble provides practice management software, workflows and integrations for private medical practices.
Swiss clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer.
French startup focused on expanding access to preventive health testing.
The Efferon company develops devices with polymer sorbents that help purify the blood during severe conditions of patients with COVID-19.
ultra-fast enzyme engineering platform.
UroMems is a medical device company developing smart active implantable technology to treat stress urinary incontinence in women and men.
Developer of MRI polarizers and hyperpolarized imaging agents.
Reports & briefings
September 2026 Startup Funding Report
49 funding rounds and $6.6B disclosed. Mistral AI leads the edition; explore the companies, investors and stage breakdown.
Sep 21 – 27, 2026 Startup Funding Weekly
23 funding rounds and $1.2B disclosed. TEKEVER leads the edition; explore the companies, investors and stage breakdown.
Sep 14 – 20, 2026 Startup Funding Weekly
3 European funding rounds and $387.8M disclosed. EUCLYD leads the edition; explore the companies, investors and stage breakdown.
Active investors
| Investor | Rounds | Led | Recent investments |
|---|---|---|---|
| 01General Catalyst | 13 | 1 | DwellyNeko Health |
| 02Balderton Capital | 12 | 1 | SpottThe Exploration Company |
| 03Y Combinator | 12 | 0 | SpottConveo |
| 04British Business Bank | 11 | 0 | Certain EnergyAlchemab Therapeutics |